Andrew T. Millican

710 total citations
15 papers, 538 citations indexed

About

Andrew T. Millican is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Organic Chemistry. According to data from OpenAlex, Andrew T. Millican has authored 15 papers receiving a total of 538 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Radiology, Nuclear Medicine and Imaging and 7 papers in Organic Chemistry. Recurrent topics in Andrew T. Millican's work include Monoclonal and Polyclonal Antibodies Research (6 papers), Chemical Synthesis and Analysis (5 papers) and Radiopharmaceutical Chemistry and Applications (5 papers). Andrew T. Millican is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (6 papers), Chemical Synthesis and Analysis (5 papers) and Radiopharmaceutical Chemistry and Applications (5 papers). Andrew T. Millican collaborates with scholars based in United Kingdom, Japan and United States. Andrew T. Millican's co-authors include David Parker, Kenneth Millar, Nigel R. A. Beeley, Michael A. W. Eaton, Byron A. Boyce, Karl J. Jankowski, Alice Harrison, J. Richard Morphy, J. P. Cox and Ritu Kataky and has published in prestigious journals such as Tetrahedron, Journal of Pharmaceutical Sciences and Synthesis.

In The Last Decade

Andrew T. Millican

15 papers receiving 484 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrew T. Millican United Kingdom 12 281 223 144 140 93 15 538
Byron A. Boyce United Kingdom 10 136 0.5× 141 0.6× 98 0.7× 102 0.7× 72 0.8× 12 353
Jin‐Cong Zhuo Switzerland 14 165 0.6× 208 0.9× 244 1.7× 245 1.8× 71 0.8× 38 762
Juozas Domarkas United Kingdom 16 215 0.8× 143 0.6× 239 1.7× 181 1.3× 85 0.9× 28 718
Amy L. Vāvere United States 15 436 1.6× 192 0.9× 223 1.5× 90 0.6× 130 1.4× 23 928
Margaret S. Cooper United Kingdom 13 132 0.5× 157 0.7× 197 1.4× 79 0.6× 48 0.5× 23 536
Herta Reile Germany 13 112 0.4× 432 1.9× 195 1.4× 216 1.5× 41 0.4× 20 719
Louis Theodore United States 16 693 2.5× 193 0.9× 193 1.3× 186 1.3× 29 0.3× 24 1.0k
Min K. Moi United States 12 638 2.3× 255 1.1× 151 1.0× 159 1.1× 132 1.4× 14 855
Shineng Luo China 15 282 1.0× 274 1.2× 147 1.0× 105 0.8× 44 0.5× 41 622
Milind Rajopadhye United States 18 495 1.8× 233 1.0× 412 2.9× 255 1.8× 44 0.5× 32 1.2k

Countries citing papers authored by Andrew T. Millican

Since Specialization
Citations

This map shows the geographic impact of Andrew T. Millican's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew T. Millican with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew T. Millican more than expected).

Fields of papers citing papers by Andrew T. Millican

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew T. Millican. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew T. Millican. The network helps show where Andrew T. Millican may publish in the future.

Co-authorship network of co-authors of Andrew T. Millican

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew T. Millican. A scholar is included among the top collaborators of Andrew T. Millican based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew T. Millican. Andrew T. Millican is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Wang, Xiaoen, N. Willmott, Surinder K. Chander, et al.. (1997). Conversion of highly malignant colon cancer from an aggressive to a controlled disease by oral administration of a metalloproteinase inhibitor. Clinical & Experimental Metastasis. 15(2). 184–195. 48 indexed citations
2.
Chander, Surinder K., Pari Antoniw, Nigel R. A. Beeley, et al.. (1995). An in Vivo Model for Screening Peptidomimetic Inhibitors of Gelatinase A. Journal of Pharmaceutical Sciences. 84(4). 404–409. 10 indexed citations
3.
Porter, John, Nigel R. A. Beeley, Byron A. Boyce, et al.. (1994). Potent and selective inhibitors of gelatinase-a 1. hydroxamic acid derivatives. Bioorganic & Medicinal Chemistry Letters. 4(23). 2741–2746. 33 indexed citations
4.
Morphy, J. Richard, Nigel R. A. Beeley, Byron A. Boyce, et al.. (1994). Potent and selective inhibitors of gelatinase-A 2. carboxylic and phosphonic acid derivatives. Bioorganic & Medicinal Chemistry Letters. 4(23). 2747–2752. 31 indexed citations
6.
Jankowski, Karl J., David Parker, Byron A. Boyce, et al.. (1992). Synthesis of New Macrocyclic Amino-Phosphinic Acid Complexing Agents and TheirC-andP-Functionalised Derivatives for Protein Linkage. Synthesis. 1992(1/2). 63–68. 27 indexed citations
7.
Harrison, A., David Parker, Karl J. Jankowski, et al.. (1991). The in vivo release of 90Y from cyclic and acyclic ligand-antibody conjugates. International Journal of Radiation Applications and Instrumentation Part B Nuclear Medicine and Biology. 18(5). 469–476. 62 indexed citations
8.
Mann, John, et al.. (1991). The synthesis of novel bifunctional linker molecules. Tetrahedron. 47(28). 5231–5236. 6 indexed citations
10.
Lyons, A. Bruce, David J. King, Raymond J. Owens, et al.. (1990). Site-specific attachment to recombinant antibodies via introduced surface cysteine residues. Protein Engineering Design and Selection. 3(8). 703–708. 53 indexed citations
11.
Morphy, J. Richard, David Parker, Ritu Kataky, et al.. (1990). Towards tumour targeting with copper-radiolabelled macrocycle–antibody conjugates: synthesis, antibody linkage, and complexation behaviour. Journal of the Chemical Society Perkin Transactions 2. 573–585. 31 indexed citations
12.
Cox, J. P., Karl J. Jankowski, Ritu Kataky, et al.. (1989). Synthesis of a kinetically stable yttrium-90 labelled macrocycle–antibody conjugate. Journal of the Chemical Society Chemical Communications. 797–798. 65 indexed citations
13.
Craig, Andrew S., I. M. HELPS, Karl J. Jankowski, et al.. (1989). Towards tumour imaging with indium-111 labelled macrocycle–antibody conjugates. Journal of the Chemical Society Chemical Communications. 794–796. 40 indexed citations
14.
Morphy, J. Richard, David Parker, Ritu Kataky, et al.. (1989). Towards tumour targeting with copper-radiolabelled macrocycle–antibody conjugates. Journal of the Chemical Society Chemical Communications. 792–794. 24 indexed citations
15.
Morphy, J. Richard, David Parker, Rikki Alexander, et al.. (1988). Antibody labelling with functionalised cyclam macrocycles. Journal of the Chemical Society Chemical Communications. 156–156. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026